Related Experiment Video
Updated: Apr 29, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Donor cell myeloid sarcoma
Mark A Walshauser1, Aileen Go2, Payal Sojitra3
1Division of Hematology & Oncology, Department of Internal Medicine, Loyola University Medical Center, Maywood, IL 60153, USA ; Division of Hematology & Oncology, Department of Medicine, Cardinal Bernardin Cancer Center, 2160 South First Avenue, Maywood, IL 60153, USA.
Donor cell malignancies are a rare complication of allogeneic bone marrow transplantation. This case highlights donor cell myeloid sarcoma affecting the stomach and heart in a transplant recipient.
Area of Science:
- Hematology
- Oncology
- Transplantation
Background:
- Allogeneic bone marrow transplantation (BMT) can lead to rare complications.
- Donor cell-derived malignancies represent a unique post-transplant event.
- Myeloid sarcoma is an extramedullary tumor of myeloid blasts.
Purpose of the Study:
- To report a rare case of donor cell-derived myeloid sarcoma.
- To describe the occurrence of this malignancy in the stomach and myocardium.
- To add to the literature on complications following allogeneic BMT.
Main Methods:
- Case presentation of a 56-year-old male recipient.
- Review of clinical course and diagnostic findings.
- Histopathological confirmation of donor origin.
Main Results:
- The patient developed myeloid sarcoma originating from donor cells.
- The malignancy manifested in unusual sites: stomach and myocardium.
- This represents a rare instance of extramedullary disease post-BMT.
Conclusions:
- Donor cell-derived myeloid sarcoma is a rare but significant complication.
- The stomach and myocardium are potential sites for this malignancy.
- Awareness is crucial for timely diagnosis and management in BMT recipients.
More Related Videos
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Differentiation of Common Myeloid Progenitor Cells